Clinical Trial

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Study acronym: ATS22
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to \<13 years of age.
Protocol Amendment History 27 amendments
This ClinicalTrials.gov record has been amended 27 times since 2020-05-05; most recent amendment 2026-02-09.
Status change: Not Yet Recruiting → Recruiting 2020-11-20
Trial Details
NCT Number NCT04378790
Lead Sponsor Jaeb Center for Health Research
Collaborators: National Eye Institute (NEI), Pediatric Eye Disease Investigator Group
Conditions Amblyopia
Enrollment 544 participants
Start Date 2020-12-08
Primary Completion 2028-05-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-11